Roger D. Kornberg's most recent trade in Xenetic Biosciences Inc was a trade of 2,500 Stock Options done . Disclosure was reported to the exchange on Dec. 11, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Xenetic Biosciences Inc | Roger Kornberg D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2024 | 2,500 | 2,500 | - | - | Stock Options | |
Cocrystal Pharma Inc | Roger D. Kornberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 28,109 | 28,109 (0%) | 0% | - | Common Stock | |
Xenetic Biosciences Inc | Roger D. Kornberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 2,500 | 2,500 | - | - | Stock Options | |
Cocrystal Pharma Inc | Roger D. Kornberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 24,417 | 24,417 | - | - | Stock Options (Right to Buy) | |
Cocrystal Pharma Inc | Roger D. Kornberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 280,000 | 280,000 | - | - | Stock Options (Right to Buy) | |
Xenetic Biosciences Inc | Roger D. Kornberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 25,000 | 25,000 | - | - | Stock Options | |
Cocrystal Pharma Inc | Roger D. Kornberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 65,000 | 65,000 | - | - | Stock Options (Right to Buy) | |
Cocrystal Pharma Inc | Roger D. Kornberg | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 50,000 | 50,000 | - | - | Stock Options (Right to Buy) |